RxDoctor Payments Data

Taylor Burger, NP

Acute Care · Lambertville, MINPI 1285340794

Payments from drug & device makers

$820in general payments, 2019–2025

Across 42 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Atricure, Inc.$125
  • Amgen$121
  • Medtronic$103
  • Novartis$102
  • Lexicon Pharmaceuticals, Inc.$70
  • Kiniksa Pharmaceuticals International, PLC$64
  • plus $236 from 8 others

What the payments were for

  • Food & beverage$820100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$820 in reported general payments places this provider in the 70th percentile of 567 acute care providers in Michigan.

See all acute care providers in Michigan

Medicare billing

Part B allowed, 2024
$54,071
Medicare patients
422
Services billed
739

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban94$89,076
BrilintaTicagrelor89$48,801
JardianceEmpagliflozin22$25,034
XareltoRivaroxaban15$21,523
EntrestoSacubitril/Valsartan23$17,410
Atorvastatin Calcium129$1,528
Ezetimibe35$1,250
Midodrine Hcl12$969
ClopidogrelClopidogrel Bisulfate76$742
Metoprolol Tartrate130$712
Amlodipine Besylate131$664
Isosorbide Mononitrate ErIsosorbide Mononitrate57$640
Bumetanide11$555
Metoprolol Succinate41$550
Carvedilol83$459

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$15$48,80189 claims
Boehringer IngelheimJardiance$35$25,03422 claims
Johnson & JohnsonXarelto$57$21,52315 claims
NovartisEntresto$102$17,41023 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 567 acute care providers in Michigan.

Other acute care in Lambertville

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →